The Nucleotide-binding oligomerization domain-like receptor pyrin domains-containing 3 (NLRP3) inflammasome, a new molecular marker of DCM, is activated by impaired insulin metabolic signaling, high FFA levels, and hyperglycemia (Pal et al., 2017). This evidence concerns the gene INS and familial dilated cardiomyopathy.